Polyethylene Glycol (3350) Powder, For Solution
NDC Package 51079-306-30
Package Information
Polyethylene Glycol (3350) powders is •do not take more than directed unless advised by your doctor•adults and children 17 years of age and older:•stir and dissolve the contents of one pouch (17 g) into any 4 to 8 ounces of beverage (cold, hot or room temperature) then drink•use once a day•use no more than 7 days•children 16 years of age or under: ask a doctor. This formulation utilizes a powder, for solution delivery system. Marketed by Mylan Institutional Inc., this product is identified by NDC 51079-306 and is authorized under FDA application ANDA078915.
Identification & Billing
- RxCUI: 876193 - polyethylene glycol 3350 17 GM Powder for Oral Solution
- RxCUI: 876193 - polyethylene glycol 3350 17000 MG Powder for Oral Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 51079 - Mylan Institutional Inc.
- 51079-306 - Polyethylene Glycol (3350)
- 51079-306-30 - 30 POUCH in 1 CARTON / 17 g in 1 POUCH (51079-306-01)
- 51079-306 - Polyethylene Glycol (3350)
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 51079-306-30 identifies a specific commercial package of 30 pouch in 1 carton / 17 g in 1 pouch (51079-306-01) of Polyethylene Glycol (3350), a human over the counter drug labeled by Mylan Institutional Inc.. This powder, for solution is formulated for oral use and contains polyethylene glycol 3500 as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Mylan Institutional Inc. on October 12, 2009. The current certification is valid through December 31, 2027.
How is this Mylan Institutional Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 51079030630. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.